The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus

Figure 3

Effect of canagliflozin on glucose and lipid metabolism in diabetic mice. (a) Body weight, (b) blood glucose after intraperitoneal glucose tolerance test, (c) the level of plasma ANGPTL3, and (d–g) the level of TC, TG, HDL-c, and LDL-c.

(a)

(b)

(c)

(d)

(e)

(f)

(g)